Oct 6, 2026 09:20AM
Oct 6, 2026 09:19AM
Sep 9, 2026 11:55AM
Jul 22, 2026 08:11AM
Jul 22, 2026 08:08AM
Jun 22, 2026 08:01AM
Jun 22, 2026 08:00AM bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
May 27, 2026 08:01AM
May 27, 2026 08:00AM
Apr 28, 2026 09:16AM
Apr 7, 2026 08:00AM
Mar 13, 2026 08:01AM
Mar 13, 2026 08:00AM
May 20, 2025 09:02AM bioAffinity (BIAF) Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 20, 2025 09:00AM
Mar 31, 2025 09:28AM
Mar 31, 2025 09:28AM
Mar 28, 2025 09:00AM
Mar 6, 2025 08:03AM
Mar 6, 2025 08:00AM
Nov 14, 2024 08:00AM bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
Nov 4, 2024 08:02AM
Nov 4, 2024 08:00AM
Jul 12, 2024 09:35AM
Jul 5, 2024 09:00AM
Jan 5, 2024 09:00AM
Sep 19, 2023 08:00AM
May 15, 2023 08:00AM bioAffinity Technologies Reports First Quarter 2023 Financial Results
Dec 19, 2022 11:33AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All